Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy- and prostate volume-adjusted biopsy scheme-Reference-Cited by-同舟云学术

Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy- and prostate volume-adjusted biopsy scheme

Published:2011-12-06 Issue:2 Volume:15 Page:202-209
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Nomura M,Ito K,Miyakubo M,Sekine Y,Tamura Y,Shimizu N,Aoki S,Suzuki K

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

http://www.nature.com/articles/pcan201162.pdf

Reference31 articles.

1. Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009; 360: 1320–1328.

2. Hugosson J, Carlsson S, Aus G, Bergdahl S, Khatami A, Lodding P et al. Mortality results from the Göteborg randomised population-based prostate-cancer screening trial. Lancet Oncol 2010; 11: 725–732.

3. Vashi AR, Wojno KJ, Gillespie B, Oesterling JE . A model for the number of cores per prostate biopsy based on patient age and prostate gland volume. J Urol 1998; 159: 920–924.

4. Ito K, Ohi M, Yamamoto T, Miyamoto S, Kurokawa K, Fukabori Y et al. The diagnostic accuracy of the age-adjusted and prostate volume-adjusted biopsy method in males with prostate specific antigen levels of 4.1–10.0 ng/ml. Cancer 2002; 95: 2112–2119.

5. Eastham JA, May R, Robertson JL, Sartor O, Kattan MW . Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/ml. Urology 1999; 54: 709–713.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. L ong‐term longitudinal changes in baseline PSA distribution and estimated prevalence of prostate cancer in male Japanese participants of population‐based PSA screening;International Journal of Cancer;2018-05-14

2. The roles of prostate-specific antigen (PSA) density, prostate volume, and their zone-adjusted derivatives in predicting prostate cancer in patients with PSA less than 20.0 ng/mL;Andrology;2017-04-13

3. Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis;Annals of Oncology;2015-05

4. Prostate cancer in Asian men;Nature Reviews Urology;2014-03-04

5. Prostate Cancer Nomograms: A Review of Their Use in Cancer Detection and Treatment;Current Urology Reports;2014-01-23